Ram S, Cullinane M, Blom A M, Gulati S, McQuillen D P, Monks B G, O'Connell C, Boden R, Elkins C, Pangburn M K, Dahlbäck B, Rice P A
Evans Biomedical Research Center, Boston Medical Center, Boston, Massachusetts 02118, USA.
J Exp Med. 2001 Feb 5;193(3):281-95. doi: 10.1084/jem.193.3.281.
We screened 29 strains of Neisseria gonorrhoeae and found 16/21 strains that resisted killing by normal human serum and 0/8 serum sensitive strains that bound the complement regulator, C4b-binding protein (C4bp). Microbial surface-bound C4bp demonstrated cofactor activity. We constructed gonococcal strains with hybrid porin (Por) molecules derived from each of the major serogroups (Por1A and Por1B) of N. gonorrhoeae, and showed that the loop 1 of Por1A is required for C4bp binding. Por1B loops 5 and 7 of serum-resistant gonococci together formed a negatively charged C4bp-binding domain. C4bp-Por1B interactions were ionic in nature (inhibited by high salt or by heparin), whereas the C4bp-Por1A bond was hydrophobic. Only recombinant C4bp mutant molecules containing the NH2-terminal alpha-chain short consensus repeat (SCR1) bound to both Por1A and Por1B gonococci, suggesting that SCR1 contained Por binding sites. C4bp alpha-chain monomers did not bind gonococci, indicating that the polymeric form of C4bp was required for binding. Using fAb fragments against C4bp SCR1, C4bp binding to Por1A and Por1B strains was inhibited in a complement-dependent serum bactericidal assay. This resulted in complete killing of these otherwise fully serum resistant strains in only 10% normal serum, underscoring the importance of C4bp in mediating gonococcal serum resistance.
我们筛选了29株淋病奈瑟菌,发现21株中有16株能抵抗正常人血清的杀伤作用,而8株血清敏感菌株中没有能结合补体调节蛋白C4b结合蛋白(C4bp)的。微生物表面结合的C4bp表现出辅因子活性。我们构建了含有淋病奈瑟菌各主要血清群(Por1A和Por1B)来源的杂合孔蛋白(Por)分子的淋球菌菌株,并表明Por1A的环1是C4bp结合所必需的。血清抗性淋球菌的Por1B环5和环7共同形成了一个带负电荷的C4bp结合结构域。C4bp与Por1B的相互作用本质上是离子性的(受高盐或肝素抑制),而C4bp与Por1A的结合是疏水性的。只有含有NH2末端α链短共有重复序列(SCR1)的重组C4bp突变分子能与Por1A和Por1B淋球菌结合,这表明SCR1包含Por结合位点。C4bpα链单体不结合淋球菌,表明C4bp的聚合形式是结合所必需的。在补体依赖性血清杀菌试验中,使用针对C4bp SCR1的单克隆抗体片段可抑制C4bp与Por1A和Por1B菌株的结合。这导致这些原本完全血清抗性的菌株在仅10%的正常血清中就被完全杀死,突出了C4bp在介导淋球菌血清抗性中的重要性。